DLA
AMGN icon

Douglas Lane & Associates’s Amgen AMGN Stock Holding History

Douglas Lane & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.72M Sell
13,032
-160
-1% -$54.8K 0.06% 132
2026
Q1 		$4.64M Buy
13,192
+156
+1% +$55.6K 0.07% 130
2025
Q4 		$4.27M Sell
13,036
-437
-3% -$139K 0.06% 132
2025
Q3 		$3.8M Buy
13,473
+90
+0.7% +$26.1K 0.05% 136
2025
Q2 		$3.74M Sell
13,383
-256
-2% -$72.5K 0.05% 133
2025
Q1 		$4.25M Sell
13,639
-739
-5% -$218K 0.06% 132
2024
Q4 		$3.75M Buy
14,378
+38
+0.3% +$11.3K 0.05% 134
2024
Q3 		$4.62M Sell
14,340
-61
-0.4% -$20K 0.06% 133
2024
Q2 		$4.5M Sell
14,401
-344
-2% -$101K 0.06% 133
2024
Q1 		$4.19M Sell
14,745
-50
-0.3% -$14.6K 0.06% 132
2023
Q4 		$4.26M Sell
14,795
-480
-3% -$131K 0.07% 128
2023
Q3 		$4.11M Buy
15,275
+384
+3% +$95.8K 0.07% 122
2023
Q2 		$3.31M Sell
14,891
-91
-0.6% -$21.1K 0.05% 126
2023
Q1 		$3.62M Sell
14,982
-287
-2% -$70.5K 0.06% 124
2022
Q4 		$4.01M Sell
15,269
-1,100
-7% -$295K 0.07% 122
2022
Q3 		$3.69M Sell
16,369
-362
-2% -$87.7K 0.07% 122
2022
Q2 		$4.07M Sell
16,731
-2,267
-12% -$556K 0.07% 121
2022
Q1 		$4.59M Sell
18,998
-3,376
-15% -$776K 0.06% 121
2021
Q4 		$5.03M Sell
22,374
-975
-4% -$206K 0.07% 118
2021
Q3 		$4.96M Sell
23,349
-3,330
-12% -$766K 0.07% 116
2021
Q2 		$6.5M Sell
26,679
-5,130
-16% -$1.26M 0.09% 110
2021
Q1 		$7.91M Sell
31,809
-4,050
-11% -$966K 0.12% 108
2020
Q4 		$8.24M Sell
35,859
-3,780
-10% -$872K 0.14% 106
2020
Q3 		$10.1M Sell
39,639
-4,618
-10% -$1.14M 0.2% 101
2020
Q2 		$10.4M Sell
44,257
-3,165
-7% -$722K 0.22% 98
2020
Q1 		$9.61M Sell
47,422
-2,002
-4% -$437K 0.25% 94
2019
Q4 		$11.9M Sell
49,424
-2,318
-4% -$511K 0.22% 96
2019
Q3 		$10M Sell
51,742
-10,389
-17% -$1.99M 0.2% 100
2019
Q2 		$11.4M Sell
62,131
-14,319
-19% -$2.56M 0.22% 98
2019
Q1 		$14.5M Sell
76,450
-7,695
-9% -$1.47M 0.3% 87
2018
Q4 		$16.4M Sell
84,145
-6,020
-7% -$1.17M 0.39% 77
2018
Q3 		$18.7M Sell
90,165
-4,466
-5% -$880K 0.37% 80
2018
Q2 		$17.5M Sell
94,631
-21,699
-19% -$3.84M 0.37% 83
2018
Q1 		$19.8M Sell
116,330
-20,699
-15% -$3.8M 0.43% 81
2017
Q4 		$23.8M Sell
137,029
-21,578
-14% -$3.82M 0.5% 69
2017
Q3 		$29.6M Sell
158,607
-73,599
-32% -$13M 0.68% 65
2017
Q2 		$40M Sell
232,206
-64,439
-22% -$10.5M 0.94% 45
2017
Q1 		$48.7M Sell
296,645
-13,973
-4% -$2.32M 1.21% 30
2016
Q4 		$45.4M Sell
310,618
-7,630
-2% -$1.15M 1.16% 35
2016
Q3 		$53.1M Sell
318,248
-12,580
-4% -$2.13M 1.42% 21
2016
Q2 		$50.3M Sell
330,828
-10,111
-3% -$1.57M 1.44% 18
2016
Q1 		$51.1M Buy
+340,939
New +$50.7M 1.4% 20

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Douglas Lane & Associates's AMGN Position: Q2 2026 in Review

Douglas Lane & Associates reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $54.8K and leaving 13,032 shares worth $4.72M. The position accounts for 0.06% of the portfolio, ranked #132.

Douglas Lane & Associates first reported a position in AMGN in Q1 2016 and has held it in 42 quarters since. The position peaked at $53.1M in Q3 2016. 1,283 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Douglas Lane & Associates held 13,032 shares of Amgen worth $4.72M as of Q2 2026.
  • Douglas Lane & Associates sold 160 Amgen shares in Q2 2026, an estimated $54.8K.
  • Amgen made up 0.06% of Douglas Lane & Associates's portfolio in Q2 2026, its #132 holding.
  • Douglas Lane & Associates first reported a position in Amgen in Q1 2016 and has held it in 42 quarters since.
  • Douglas Lane & Associates's Amgen position peaked at $53.1M in Q3 2016.
  • 1,283 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.